New approach to the diagnosis of growth hormone deficiency in adults
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Ghigo E, Aimaretti G, Gianotti L, Bellone J, Arvat E, Camanni F. New approach to the diagnosis of growth hormone deficiency in adults. Eur J Endocrinol 1996;134:352–6. ISSN 0804–4643 Pyridostigmine (PD), a muscarinic cholinergic agonist, and arginine (ARG) clearly increase the growth hormone (GH) response to growth hormone-releasing hormone (GHRH) in man. The current study was undertaken to investigate the value and safety of PD + GHRH and ARG + GHRH tests as well as the measurement of serum insulin-like growth factor I (IGF-I) in diagnosing GH deficiency in adults. Fifty-four patients considered GH deficient from extensive organic or idiopathic pituitary disease and 326 healthy adults were studied. The IGF-I concentrations were lower than the 3rd percentile of normal values in only 31 of the 54 (57.4%) patients with hypopituitarism. However, the IGF-I levels in hypopituitary patients and in normal subjects overlapped more frequently between 41 and 60 years (50%) and between 61 and 80 years (92.3%) as opposed to between 20 and 40 years (8.6%). In contrast to the IGF-I measurement, the ranges of peak GH responses to PD + GHRH and ARG + GHRH tests were clearly differentiated between the hypopituitary (0.2–6.8 and 0.1–9.5 μg/l, respectively) and normal subjects 17.7–114 and 16.1–119 μg/l, respectively). However, the PD + GHRH test was reliable only in subjects of 20–40 years of age. In conclusion, IGF-I measurement had no value in the diagnosis of GH deficiency in adults aged over 40 years, but is reliable enough when young adults of 20–40 years of age are considered. Both PD + GHRH and ARG + GHRH testing should be considered more reliable biochemical measurements of GH deficiency. In contrast to the PD + GHRH test, the ARG + GHRH test is reliable throughout the adult lifespan and appears to be the most appropriate for patient compliance and safety. F Camanni, Divisione di Endocrinologia, Ospedale Molinette, C.so Dogliotti 14, 10126 Torino, Italy
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The cholinergic hypothesis of geriatric memory dysfunction
Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545 · cited 1×
“On the other hand, the existence of an impaired function of the cholinergic nervous system in old people has been evidenced by others ( 25 , 26).”
Background
Cited by
Items 101–200 of 255
Grottoli, S., Razzore, P., Gaia, D., Gasperi, M., Giusti, M., Colao, A., CICCARELLI, E., Gasco, V., Martino, E., Ghigo, E., et al. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03345139 · Cited by 33
Self-citationGrowth hormone deficiency and human immunodeficiency virus
Rochira, V., & Guaraldi, G. (2017) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2017.02.006 · Cited by 34
“5 g/k g is then infused intravenously for 30 minutes (from 0 min to +30 min, up to a dose of 30 g) (Figu re 2) [41-43].”
MethodDonaubauer, J., Kieß, W., Kratzsch, J., Nowak, T., Steinkamp, H., Willgerodt, H., Keller, E., & Study Group (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01739.x · Cited by 32
“…cut-off ranges with sensitivity of 100% and specificity of 97·5% for the ARG + GHRH and PD + GHRH tests are consistent with data from the literature (Andersen et al., 1996; Ghigo et al., 1996a, 1996b; Longobardi et al., 1996; Valetto et al., 1996; Aimaretti et al., 1998, 2000a; Hoeck et al., 2000).”
BackgroundMethodResultInfluentialPrakash, A., & Goa, K. L. (1999) · BioDrugs · doi:10.2165/00063030-199912020-00007 · Cited by 34
“5 g/kg bodyweight (up to maximum of 30g) has been reported to be a reliable, reproducible and age-independent provocative test of growth hormone secretion in adults,[46-48] and is reportedly at least as sensitive 148 Prakash & Goa”
Maccario, M., Gauna, C., Massimo, P., Vito, L. D., Rossetto, R., Oleandri, S. E., Grottoli, S., Ganzaroli, C., Aimaretti, G., & Ghigo, E. (1999) · Journal of Endocrinological Investigation · doi:10.1007/bf03343585 · Cited by 32
Self-citationLink, K., Moëll, C., Österberg, K., Persson, R., Ørbæk, P., Garwicz, S., Cavallin-Ståhl, E. K., & Erfurth, E. M. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02637.x · Cited by 31
“with CRT, at a target dose of 24 Gy ( 18-30 ), at a median of 20 years previously”
MethodDiagnosis of GH deficiency in adults
Ghigo, E., Aimaretti, G., Corneli, G., BELLONE, J., Arvat, E., Maccario, M., & Camanni, F. (1998) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(98)80010-5 · Cited by 30
Self-citationUpdate on the diagnosis of GH deficiency in adults
Abs, R. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.148s003 · Cited by 32
Broglio, F., Benso, A. S., Gottero, C., Vito, L., Aimaretti, G., Fubini, A., Arvat, E., Bobbio, M., & Ghigo, E. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1420157 · Cited by 31
Self-citationThe diagnosis of growth hormone deficiency (GHD) in successfully treated acromegalic patients
Murray, R. D., Peacey, S. R., Rahim, A., Toogood, A. A., Thorner, M. O., & Shalet, S. M. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01189.x · Cited by 29
“When severely GHD adults are stratified for the age ranges 20±40, 41±60 and 61±80 years, serum IGF-I is below the normal range (2 2 ́0 to 1 2 ́0 SDS) in 91 ́4%, 50 ́0% and 7 ́7%, respectively (Ghigo et al., 1996).”
BackgroundGianotti, L., Broglio, F., Ramunni, J., Lanfranco, F., Gauna, C., Benso, A. S., Zanello, M., Arvat, E., & Ghigo, E. (1998) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/bf03339990 · Cited by 28
Self-citationDiagnostic Value of Serum IGF-I and IGFBP-3 in Growth Hormone Disorders in Adults
Kim, H. J., Kwon, S. H., Kim, S. W., Park, D. J., Shin, C. S., Park, K. S., Kim, S. Y., Cho, B.-Y., & Lee, H. K. (2001) · Hormone Research in Paediatrics · doi:10.1159/000048103 · Cited by 29
Plasma IGF-I is a useful marker of growth hormone deficiency in adults
Span, J. P. T., PIETERS, G. F. F. M., Sweep, F. C. G. J., Swinkels, L. M., & SMALS, A. G. H. (1999) · Journal of Endocrinological Investigation · doi:10.1007/bf03343588 · Cited by 28
Somma, C. D., Pivonello, R., Pizza, G., Rosa, A. D., Lombardi, G., Colao, A., & Savastano, S. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346577 · Cited by 28
Murray, R. D., Bidlingmaier, M., Strasburger, C. J., & Shalet, S. M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2055 · Cited by 28
“(8) determined the prevalence of IGF-I values below the normative range in a cohort of GHD adults aged 20–80 yr.”
BackgroundAlström syndrome is associated with short stature and reduced GH reserve
Romano, S., Maffei, P., Bettini, V., Milan, G., Favaretto, F., Gardiman, M. P., Marshall, J. D., Greggio, N. A., Pozzan, G. B., Collin, G. B., et al. (2013) · Clinical Endocrinology · doi:10.1111/cen.12180 · Cited by 28
Karamouzis, I., Pagano, L., Prodam, F., Mele, C., Zavattaro, M., Busti, A., Marzullo, P., & Aimaretti, G. (2015) · Endocrine · doi:10.1007/s12020-015-0796-2 · Cited by 28
Self-citationGrowth Hormone Deficiency: Diagnostic Principles and Practice
Ranke, M. B. (2011) · KARGER eBooks · doi:10.1159/000327405 · Cited by 29
Giavoli, C., Ferrante, E., Profka, E., Olgiati, L., Bergamaschi, S., Ronchi, C. L., Verrua, E., Filopanti, M., Passeri, E., Montefusco, L. B., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0317 · Cited by 27
Incidence of a Second Tumor in Hypopituitary Patients Operated for Pituitary Tumors
Erfurth, E. M., Bülow, B., Mikoczy, Z., & Hagmar, L. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7234 · Cited by 26
“About 50% of GH-deficient patients between 40 and 60 yr of age have serum IGF-I levels below the normal range, and the remaining subjects have IGF-I levels within the low normal range ( 37 ).”
BackgroundDIAGNOSIS AND MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS
Stavrou, S., & Kleinberg, D. L. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70201-2 · Cited by 28
Bisi, G., Podio, V., Valetto, M. R., Broglio, F., Bertuccio, G., Rió, G. D., Boghen, M. F., Berti, F., Ee, M., & Ghigo, E. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1400322 · Cited by 26
“The increase in circulating IGF-I levels that we found in the present study after the subcutaneous administration of 20 mg/kg rhIGF-I overlaps with that reported by other authors (1, 34‐37) and it must be emphasized that it remained within the high normal range of basal IGF-I levels in adulthood ( 38 ).”
ResultSelf-citationShort Procedure of GHRH Plus Arginine Test in Clinical Practice
Aimaretti, G., Bellone, S., Baffoni, C., Corneli, G., Origlia, C., Vito, L. D., Rovere, S., Arvat, E., Camanni, F., & Ghigo, E. (2001) · Pituitary · doi:10.1023/a:1015306705154 · Cited by 28
“In fact the diagnosis of severe GHD in adults relies on the demonstration of severely impaired GH response to provocative test [3–5,26].”
BackgroundMethodInfluentialSelf-citationRota, F., Savanelli, M. C., Tauchmanova, L., Savastano, S., Lombardi, G., Colao, A., & Di Somma, C. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03345574 · Cited by 25
Steyn, F. J., Ngo, S. T., Lee, J. D., Leong, J. W., Buckley, A. J., Veldhuis, J. D., McCombe, P., Chen, C., & Bellingham, M. C. (2012) · Endocrinology · doi:10.1210/en.2011-2171 · Cited by 26
“Exogenous administration of GHRH directly stimulates GH release and provides an indication of the secretory capacity of the somatotroph (28).”
BackgroundToogood, A., & Shalet, S. M. (1997) · Acta Paediatrica · doi:10.1111/j.1651-2227.1997.tb18390.x · Cited by 25
A 2024 Update on Growth Hormone Deficiency Syndrome in Adults: From Guidelines to Real Life
Aversa, L. S., Cuboni, D., Grottoli, S., Ghigo, E., & Gasco, V. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13206079 · Cited by 25
“Initially, diagnostic cut-offs for various stimulation tests were determined by identifying the minimal response observed in a group of normal subjects [56,57].”
BackgroundSelf-citationYuen, K. C. J., Bennett, R. M., Hryciw, C. A., Cook, M. B., Rhoads, S. A., & Cook, D. M. (2007) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2006.12.006 · Cited by 24
“0 lg/L by some investigators [19,20].”
Somma, C. D., Angrisani, L., Rota, F., Savanelli, M. C., Cascella, T., Belfiore, A., Orio, F., Lombardi, G., Colao, A., & Savastano, S. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03183.x · Cited by 25
GH Secretion Is Impaired in Patients with Primary Hyperparathyroidism
Gasperi, M., Cecconi, E., Grasso, L., Bartalena, L., Centoni, R., Aimaretti, G., Broglio, F., Miccoli, P., Marcocci, C., Ghigo, E., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8451 · Cited by 24
“The high prevalence of decreased serum IGF-I levels is remarkable in view of the observation that even in severe adult GH deficiency, only about half of the patients show serum IGF-I concentrations below the normal limits (12).”
BackgroundSelf-citationCorneli, G., Baldelli, R., Somma, C. D., Rovere, S., Gaia, D., Pellegrino, M., Gasco, V., Durante, C., Grottoli, S., Colao, A., et al. (2003) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(03)00010-8 · Cited by 25
Self-citationSellar Masses That Present With Severe Hyponatremia
Bordo, G., Kelly, K., McLaughlin, N., Miyamoto, S., Duong, H. T., Eisenberg, A., Chaloner, C., Cohan, P., Barkhoudarian, G., & Kelly, D. F. (2014) · Endocrine Practice · doi:10.4158/ep13370.or · Cited by 23
Chanson, P., Cailleux-Bounacer, A., Kuhn, J.-M., Weryha, G., Chabre, O., Borson-Chazot, F., Dubois, S., Vincent-Dejean, C., Brue, T., Fedou, C., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0295 · Cited by 22
IGF-I Bioactivity Better Reflects Growth Hormone Deficiency than Total IGF-I
Varewijck, A. J., Lamberts, S. W. J., Uitterlinden, P., Hofland, L. J., & Janssen, J. A. M. J. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0051 · Cited by 21
Hartman, M. L. (1998) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(98)80005-1 · Cited by 23
Management of Adult Growth Hormone Deficiency
Johannsson, G. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.11.012 · Cited by 24
“The Arg-GHRH stimulation test benefits from the potentiating of both substances and a reproducible stimulation of the GH secretion is achieved [16].”
BackgroundAimaretti, G., Colao, A. M. L., Corneli, G., Pivonello, R., Maccario, M., Morrison, K. M., Pflaum, C. D., Strasburger, C. J., Lombardi, G., & Ghigo, E. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00885.x · Cited by 21
“39 011 664 7421; E-mail: camanni@pianeta.net secretion (De Boer et al., 1995; Hoffman et al., 1994; Ghigo et al., 1996; Aimaretti et al., 1998a; GRS, 1998; Shalet et al., 1998).”
BackgroundSelf-citationPOPOVIC, V. M., Pekić, S., Doknić, M., Micić, D., Damjanovic, S. S., Žarković, M., Aimaretti, G., CORNELI, G., Ghigo, E., Deiguez, C., et al. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01835.x · Cited by 24
“The reliability of each test on its own, i.e. arginine + GHRH and GHRH + GHRP-6, which evaluate the pituitary GH releasable pool, has already been shown with normative data for both combined tests (Ghigo et al., 1996, 2001; Popovic et al., 2000).”
ResultSelf-citationPoggi, M., Pascucci, C., Monti, S., Pugliese, P., Lauri, C., Amodeo, G., Girelli, G., & Toscano, V. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03346643 · Cited by 20
Gill, M. S., Toogood, A. A., O'Neill, P. A., Thorner, M. O., Shalet, S. M., & Clayton, P. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.7.4928 · Cited by 20
“However, in a study by Ghigo et al. ( 4 ), IGF-I levels in hypopituitary patients were shown to overlap more frequently with the normal range with increasing age, such that between the ages of 61‐ 80 yr there was almost complete overlap.”
BackgroundVarewijck, A. J., Lamberts, S. W. J., van der Lely, A. J., Neggers, S. J. C. M. M., Hofland, L. J., & Janssen, J. A. M. J. L. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2558 · Cited by 20
“Previously, it has been reported in the literature that before the start of GH treatment, about 40% of the patients diagnosed as GHD may show IGF-1 levels within the normal range (16).”
BackgroundYan, M., Hernandez, M., Xu, R., & Chen, C. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500235 · Cited by 20
Maghnie, M., Pennati, M. C., Civardi, E., Iorgi, N. D., Aimaretti, G., Foschini, M. L., Corneli, G., Tinelli, C., Ghigo, E., Lorini, R., et al. (2007) · European Journal of Endocrinology · doi:10.1530/eje-06-0642 · Cited by 20
Self-citationLeal, A., Lage, M., POPOVIC, V. M., Torres, E., Koppeschaar, H. P. F., Páramo, C., Micić, D., García-Mayor, R. V., Diéguez, C., & Casanueva, F. F. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01623.x · Cited by 20
Savastano, S., Angrisani, L., Somma, C. D., Rota, F., Savanelli, M. C., Cascella, T., Orio, F., Lombardi, G., & Colao, A. (2009) · Obesity Surgery · doi:10.1007/s11695-009-9926-3 · Cited by 20
“[28].”
Verrua, E., Filopanti, M., Ronchi, C. L., Olgiati, L., Ferrante, E., Giavoli, C., Sala, E., Mantovani, G., Arosio, M., Beck‐Peccoz, P., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1115 · Cited by 18
Aimaretti, G., Baffoni, C., Ambrosio, M. R., Maccario, M., Corneli, G., Bellone, S., Gasperi, M., Uberti, E. C. D., & Ghigo, E. (2000) · Journal of Endocrinological Investigation · doi:10.1007/bf03343668 · Cited by 19
Self-citationDegerblad, M., Brismar, K., Rähn, T., & Thoren, M. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01125.x · Cited by 18
Growth Hormone Therapy in Adults
Conceição, F. L., Bojensen, A., Jørgensen, J. O. L., & Christiansen, J. S. (2001) · Frontiers in Neuroendocrinology · doi:10.1006/frne.2001.0215 · Cited by 18
Schneider, H. J., Herrmann, B. L., Schneider, M., Sievers, C., Schaaf, L., & Stalla, G. K. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02258 · Cited by 17
“To compare the two tests, we considered both the classical cut-offs of %3 and %9 ng/ml for the ITT (3, 4) and GHRHCARG test ( 5 ) respectively, and the BMI-dependent cut-off levels with %11.5, %8.0, and %4.2 ng/ml in lean (BMI!25), overweight (BMIR25 to !30), and obese (BMIR30) subjects respectively (9).”
InfluentialPatti, G., Noli, S., Capalbo, D., Allegri, A. E. M., Napoli, F., Cappa, M., Ubertini, G., Gallizia, A., Notarnicola, S., Ibba, A., et al. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00525 · Cited by 18
Bergamaschi, S., Giavoli, C., Ferrante, E., Lania, A. G., Rusconi, R., Spada, A., & Beck-Peccoz, P. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344122 · Cited by 17
“Severe GHD was defined as a peak response of serum GH <3 μg/l to insulin tolerance test or <9 μg/l to arginine+GHRH, as previously reported (15).”
MethodHolmer, H., Svensson, J., Rylander, L., Johannsson, G., Rosén, T., Bengtsson, B.-Å., Thorén, M., Höybye, C., Degerblad, M., Bramnert, M., et al. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.09.008 · Cited by 16
“The GHRH-arginine test followed the cut-off criterion for that time being (Ghigo et al., 1996).”
MethodThe robustness of diagnostic tests for GH deficiency in adults
Andersen, M. (2015) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2015.03.001 · Cited by 18
“[105] preferred the GHRH + arg test for elderly patients with suspected GHD.”
BackgroundMethodInfluentialScacchi, M., Danesi, L., Cattaneo, A., Sciortino, G., Radin, R., Ambrogio, A. G., Vitale, G., D’Angelo, E., Mirra, N., Zanaboni, L., et al. (2016) · Endocrine · doi:10.1007/s12020-016-0865-1 · Cited by 15
“According to the established criteria for the interpretation of this test [10], 19 of 68 (27.”
Insulin-like growth factor I (IGF I)
Souberbielle, J. (2006) · EMC - Biologie Médicale · doi:10.1016/s2211-9698(06)76084-8 · Cited by 15
Pivonello, R., Faggiano, A., Somma, C. D., Klain, M., Filippella, M., Salvatore, M., Lombardi, G., & Colao, A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.7.2349 · Cited by 14
Carmichael, J. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804169-7.00010-6 · Cited by 14
Pivonello, R., Faggiano, A., Arrichiello, P., Sarno, A. D., Somma, C. D., Ferone, D., Lombardi, G., & Colao, A. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01207.x · Cited by 13
“, 1997), the presence of GH deficiency was excluded prior to recruitment by performing an arginine plus GH-releasing hormone test, with a normal response of GH being greater than 33 mU/l (16 ́5 mg/l) (Ghigo et al., 1996; Colao et al., 1999a; 1999b).”
MethodGiavoli, C., Ferrante, E., Ermetici, F., Bergamaschi, S., Ronchi, C. L., Lania, A. G., Ambrosi, B., Spada, A., & Beck-Peccoz, P. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02655.x · Cited by 14
Enhancement of the peripheral sensitivity to growth hormone in adults with GH deficiency
Aimaretti, G., Fanciulli, G., Bellone, S., Maccario, M., Arvat, E., Delitala, G., Camanni, F., & Ghigo, E. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450267 · Cited by 13
Self-citationRational use of the laboratory for childhood and adult growth hormone deficiency
Pandian, R., & Nakamoto, J. M. (2004) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2004.01.009 · Cited by 14
“The first percentile GH response in normal adults is 9 lg/L [48], which is the basis of the current clinical cutoff that is used for this GH stimulation test.”
MethodEvaluation of growth hormone stimulation tests in cured acromegalic patients
Conceição, F. L., Fisker, S., Andersen, M., Kaal, A., Jørgensen, J. O. L., Vaisman, M., & Christiansen, J. S. (2003) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(03)00124-2 · Cited by 14
Ranke, M. B., Schweizer, R., & Binder, G. (2018) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2018-0025 · Cited by 12
Reproducibility and variability of the arginine test in normal adults. Comparison between sexes.
Fideleff, H. L., Frigeri, A., Sobrado, P. G. V., Llano, M., Ruibal, G., & Boquete, H. (1999) · PubMed · Cited by 12
Growth Hormone Deficiency in Elderly Patients with Hypothalamo-Pituitary Tumors
Colao, A. A. L., Cerbone, G., Pivonello, R., Klain, M., Aimaretti, G., Faggiano, A., Somma, C. D., Salvatore, M., & Lombardi, G. (1998) · Pituitary · doi:10.1023/a:1009923025853 · Cited by 12
“It should be considered that also GHRH1ATT was safe and reliable and was performed in the whole population since it causes virtually no side effects [ 22 ].”
BackgroundSelf-citationRadetti, G., Iorgi, N. D., Paganini, C., Gastaldi, R., Napoli, F., Lorini, R., & Maghnie, M. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02842.x · Cited by 11
Medic‐Stojanoska, M., Pekić, S., Ćurić, N., Djilas-Ivanovic, D., & Popovic, V. (2007) · Endocrine · doi:10.1007/s12020-007-0037-4 · Cited by 11
Conflicts with the sornatopause
Toogood, A. A., & Shalet, S. M. (1998) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(98)80009-9 · Cited by 10
Markkanen, H. M., Pekkarinen, T., Välimäki, M. J., Alfthan, H. V., Hämäläinen, E. K., & Stenman, U. (2013) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2013.06.002 · Cited by 10
Baldelli, R., Bianchi, A., Diacono, F., Passeri, M., Fusco, A., Valle, D. D. L. N. M., Poggi, M., Terlini, M., Toscano, V., Tamburrano, G., et al. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03345359 · Cited by 9
Gianotti, L., Stella, M., Bollero, D., Broglio, F., Lanfranco, F., Aimaretti, G., Destefanis, S., Casati, M., Magliacani, G., & Ghigo, E. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03343974 · Cited by 10
Self-citationPellecchia, M. T., Salvatore, E., Pivonello, R., Faggiano, A., Barone, P., Michele, G. D., Colao, A., & Filla, A. (2001) · Neurological Sciences · doi:10.1007/s100720170056 · Cited by 9
“To clarify these discordant data, we studied GH response to stimulation not only with clonidine but also with growth hormone releasing hormone plus arginine (GHRH-Arg), as this test is considered more reliable in adults [3].”
MethodBELLONE, J., BARTOLOTTA, E., Sgattoni, C., Aimaretti, G., Arvat, E., Bellone, S., Deghenghi, R., & Ghigo, E. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03347334 · Cited by 9
Self-citationDefining Growth Hormone Status in Adults with Hypopituitarism
Kaushal, K., & Shalet, S. M. (2007) · Hormone Research in Paediatrics · doi:10.1159/000101286 · Cited by 10
“Like the ITT, GHRH plus arginine distinguishes between normal and hypopituitary adults of all ages and appears superior to the GHRH-pyridostigmine test which only provides a clear differentiation between the ages of 20 and 40 [”
MethodGasco, V., Cuboni, D., Varaldo, E., Bioletto, F., Berton, A. M., Bona, C., Prencipe, N., Ghigo, E., Maccario, M., & Grottoli, S. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02081-9 · Cited by 8
“…the diagnostic cut-offs for different stimulus tests were identified by looking for the minimal response observed in a group of normal subjects [33–35]; subsequently new studies have revisited the diagnostic criteria comparing the response to the test in analysis with that of the test considered…”
BackgroundSelf-citationVarewijck, A. J., Lamberts, S. W. J., Neggers, S. J. C. M. M., Hofland, L. J., & Janssen, J. A. M. J. L. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2901 · Cited by 8
“In a substantial fraction of patients diagnosed as GHD, total IGF-I concentrations are within the normal range before starting GH therapy (13, 14).”
BackgroundCarmichael, J. D. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-380926-1.10010-0 · Cited by 8
Central Adiposity as an Important Confounder in the Diagnosis of Adult Growth Hormone Deficiency
Johannsson, G. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2020 · Cited by 8
Aspectos actuales de la obesidad
Borrajo, E. (2002) · Anales de Pediatría · Cited by 9
The use of growth hormone (GH) secretagogues in the diagnosis of GH deficiency in humans
Peino, R., Leal, A., García-Mayor, R. V., Cordido, F., Micić, D., Koppeschaar, H. P. F., Diéguez, C., & Casanueva, F. F. (1999) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(99)80020-3 · Cited by 9
Growth hormone secretion in primary and secondary hyperparathyroidism
Cecconi, E., Gasperi, M., Genovesi, M., Bogazzi, F., Grasso, L., Massimo, P., Marcocci, C., Pinchera, A., Bartalena, L., & Martino, E. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03345352 · Cited by 8
Somma, C. D., Rivellese, A. A., Pizza, G., Patti, L., Rosa, A. D., Cipriano, P., Nedi, V., Rossi, A., Lombardi, G., Colao, A., et al. (2011) · Journal of Endocrinological Investigation · doi:10.1007/bf03347036 · Cited by 7
Hypopituitarism and Growth Hormone Deficiency
Burt, M. G., & Ho, K. K. Y. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00011-1 · Cited by 10
Testing Pituitary Function in Aging Individuals
Giordano, R., Aimaretti, G., Lanfranco, F., Bo, M., Baldi, M., Broglio, F., Baldelli, R., Grottoli, S., Ghigo, E., & Arvat, E. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.07.004 · Cited by 8
“An evaluation for GHD should be considered only in patients for whom there is high suspicion for acquired hypothalamic-pituitary disease or in patients with childhood-onset GHD [14,24,45].”
BackgroundSelf-citationDiagnosis and Management of Adult Growth Hormone Deficiency
Ho, K. K. Y. (2000) · Endocrine · doi:10.1385/endo:12:2:189 · Cited by 7
Primary hyperparathyroidism is associated with marked impairment of GH response to acylated ghrelin
Cecconi, E., Bogazzi, F., Morselli, L. L., Gasperi, M., Massimo, P., Gramaglia, E., Broglio, F., Giovannetti, C., Ghigo, E., & Martino, E. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03188.x · Cited by 7
Self-citationItalian Association for Research on Brain Aging (AIRIC) Multicenter Study Group (1997) · Aging Clinical and Experimental Research · doi:10.1007/bf03340148 · Cited by 7
Diazzi, C., Brigante, G., Ferrannini, G., Ansaloni, A., Zirilli, L., Santis, M. C. D., Zona, S., Guaraldi, G., & Rochira, V. (2016) · Endocrine · doi:10.1007/s12020-016-1133-0 · Cited by 6
Acromegaly: Diagnostic Pitfalls
Freda, P. U. (2004) · The Endocrinologist · doi:10.1097/01.ten.0000139007.95472.f8 · Cited by 6
The Diagnosis of Growth Hormone Deficiency in Adults1
Andersen, M., Hangaard, J., Hagen, C., Aimaretti, G., & Ghigo, E. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.10.4288-1 · Cited by 6
Self-citationDíez, J. J. (2000) · Medicina Clínica · doi:10.1016/s0025-7753(00)71334-0 · Cited by 6
Cecconi, E., Gasperi, M., Grasso, L., Genovesi, M., Aimaretti, G., Broglio, F., Bartalena, L., Marcocci, C., & Martino, E. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03343990 · Cited by 6
Self-citationMeusel, M., Herrmann, M., Machleidt, F., Franzen, K. F., Krapalis, A. F., & Sayk, F. (2019) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00033.2018 · Cited by 5
Wang-Cheng, R. M., & Rosenfeld, J. A. (2002) · BMJ · doi:10.1136/bmjusa.02090003 · Cited by 7
Growth hormone secretagogues in pathological states: diagnostic implications
POPOVIC, V. M., Micić, D., Damjanovic, S. S., Obradović, S., Djurovic, M. N., Petakov, M. S., Grudic, D., Golubiĉić, I., Nikitović, M., Mitrović, N., et al. (1997) · Acta Paediatrica · doi:10.1111/j.1651-2227.1997.tb18384.x · Cited by 5
Juul, A. (2005) · KARGER eBooks · doi:10.1159/000088406 · Cited by 5
HIROHATA, T., Saito, N., Takano, K., Yamada, S., Son, J.-H., Yamada, S. M., Nakaguchi, H., Hoya, K., Murakami, M., Mizutani, A., et al. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0196 · Cited by 4
Varewijck, A. J., Lamberts, S. W. J., van der Lely, A. J., Neggers, S. J. C. M. M., Hofland, L. J., & Janssen, J. A. M. J. L. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0048 · Cited by 4
Markkanen, H. M., Pekkarinen, T., Hämäläinen, E. K., Välimäki, M. J., Alfthan, H. V., & Stenman, U. (2017) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2017.07.002 · Cited by 4
“earlier it was thought that age has no effect [6,24] but Colao et al.”
Background
Metadata
- Authors
- Ghigo, E., Aimaretti, G., Gianotti, L., Bellone, J., Arvat, E., & Camanni, F.
- Affiliations
- University of Turin (IT)
- Corresponding author
- Camanni, Franco
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-03
- Volume
- 134
- Issue
- 3
- Pages
- 352-356
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W1983364664
- Cited by
- 257
- References
- 1
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 3 · 2017: 7 · 2016: 3 · 2015: 11 · 2014: 4 · 2013: 11 · 2012: 9
- FWCI
- 13.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- growth hormone deficiency, adults, pyridostigmine, L-arginine, insulin-like growth factor I, hypopituitarism, pituitary disorders, test safety
- MeSH terms
- Adult, Aged, Aged, 80 and over, Arginine, Female, Humans, Hypopituitarism, Insulin-Like Growth Factor I, Male, Middle Aged, Pyridostigmine Bromide, Growth Hormone, Growth Hormone-Releasing Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.